National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 2) (PB 19 of 2017) (Cth)

PB 19 of 2017

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 2)

National Health Act 1953

I, LOUISE CLARKE, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 30^th March 2017

LOUISE CLARKE

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________________

Amendment instrument – Pharmaceutical benefits – early supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 2)

(2)This Instrument may also be cited as PB 19 of 2017.

2          Commencement

This Instrument commences on 1 April 2017.

3          Amendment of PB 120 of 2015

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1        Amendments

1. Schedule 1

insert as first item:

Abatacept Injection 125 mg in 1 mL single dose autoinjector 20 4 5

1. Schedule 1, after entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 5 mg

insert:

Brentuximab vedotin Powder for I.V. infusion 50 mg 20 200 11

1. Schedule 1, after entry for Vildagliptin with metformin in the form Tablet containing 50 mg vildagliptin with 850 mg metformin hydrochloride

insert:

Vismodegib Capsule 150 mg 20 28 2